Nitazene Control Act

119th Congress Introduced by Michael Baumgartner

The Nitazene Control Act classifies nitazenes as Schedule I drugs, restricting their use to combat overdose and addiction, impacting healthcare and law enforcement.

Introduced in House

Purpose and Intent

The Nitazene Control Act (HR 5032) aims to address the growing public health concerns associated with nitazenes, a class of synthetic opioids that have been linked to increased rates of overdose and addiction. The bill seeks to establish regulatory measures to control the distribution and use of these substances, thereby enhancing public safety and health outcomes.

Key Provisions

Scheduling of Nitazenes: The bill proposes to classify nitazenes as Schedule I controlled substances under the Controlled Substances Act. This classification indicates that nitazenes have a high potential for abuse and no accepted medical use, thereby restricting their availability.

Regulatory Framework: The legislation outlines a framework for the regulation of nitazenes, including:

Manufacturing and Distribution: Strict controls on the manufacturing and distribution of nitazenes to prevent illegal trafficking.
Penalties: Establishes penalties for violations related to the unauthorized manufacture, distribution, or possession of nitazenes.

Research and Monitoring: The bill encourages the National Institute on Drug Abuse (NIDA) to conduct research on the effects and prevalence of nitazenes, as well as to monitor trends in their use and abuse.

Affected Parties

Healthcare Providers: Medical professionals will need to adapt to the new regulations regarding nitazenes, which may impact prescribing practices.

Law Enforcement: Agencies will be tasked with enforcing the new regulations and penalties associated with nitazenes, requiring additional training and resources.

Public Health Organizations: These organizations may see increased demand for resources and support related to addiction treatment and prevention programs as a result of the bill's implementation.

Procedural Aspects

Introduced Date: The bill was introduced in the House on August 22, 2025.

Committee Referrals: Upon introduction, HR 5032 was referred to:

The Committee on Energy and Commerce
The Committee on the Judiciary

The Speaker will determine the period for consideration by these committees, which will review the bill and make recommendations for further action.

Conclusion

The Nitazene Control Act represents a proactive legislative effort to combat the risks associated with nitazenes and aims to enhance public health safety through stringent regulatory measures. As the bill progresses through the legislative process, its implications for healthcare, law enforcement, and public health will become clearer.

Bill